Silexion Therapeutics SLXN

Silexion Therapeutics Corp · Nasdaq · Biological Products, (No Diagnostic Substances) · also SLXNW

$0.15-7.71%close on Oct. 28, 2026 · volume 379K · Yahoo Finance

Price, last 47 sessions

$0.20$0.30$0.40$0.50Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $0.54 · low $0.15 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 23 →
  • 8-KOct. 26, 2026, 4:05 p.m. ETView on SEC.govOur explainer

    Amendments to articles or bylaws; fiscal year change · Submission of matters to a vote of security holders · Financial statements and exhibits

    AI summary, unreviewedSilexion Therapeutics Approves Authorized Share Capital Increase to 515.9 Million Shares and 1-for-24 Reverse Split

  • 8-KSept. 30, 2026, 8:52 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 8-KSept. 29, 2026, 10:31 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits

  • SCHEDULE 13D/ASept. 28, 2026, 4:27 p.m. ETView on SEC.gov
  • 8-KSept. 28, 2026, 8:46 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 8-KSept. 25, 2026, 4:15 p.m. ETView on SEC.gov

    Delisting notice / failure to meet listing standard

  • 8-KSept. 25, 2026, 4:05 p.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

  • 8-KAug. 21, 2026, 4:21 p.m. ETView on SEC.gov

    Delisting notice / failure to meet listing standard